OpenAlex
PricingAboutJobs
Log inGet started
Work

The use of pharmacokinetic and pharmacodynamic data to optimize the dose and schedule of an EphA2 antibody drug conjugate in-vivo

HTML

Year: 2007
Type: article
Source: Molecular Cancer Therapeutics
Authors: Krista Kinneer, María de los Milagros Cámara, Shenlan Mao, John Gooya, Ruth Moser, Damon L. Meyer, Peter D. Senter, Peter A. Kiener, Steve Coats, Bahija Jallal, David A. Tice, Dowdy Jackson
Institution: Seagen (United States)
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: EphA2, antibody-drug conjugates, pharmacokinetics, pharmacodynamics, dose optimization, receptor internalization, prostate cancer, PC-3 xenografts, dosing regimen, serum half-life, dose proportionality
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2255891139
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms